➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

ISONIAZID Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Isoniazid patents expire, and what generic alternatives are available?

Isoniazid is a drug marketed by Sandoz Inc, Anda Repository, Cmp Pharma Inc, Barr, Duramed Pharms Barr, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lilly, Mk Labs, Nexgen Pharma Inc, Panray, Perrigo, Pharmavite, Phoenix Labs Ny, Purepac Pharm, Sandoz, Sun Pharm Industries, Thepharmanetwork Llc, Watson Labs, and Whiteworth Town Plsn. and is included in thirty-four NDAs.

The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

US ANDA Litigation and Generic Entry Outlook for Isoniazid

A generic version of ISONIAZID was approved as isoniazid by THEPHARMANETWORK LLC on October 29th, 2014.

  Start Trial

Drug patent expirations by year for ISONIAZID
Drug Prices for ISONIAZID

See drug prices for ISONIAZID

Recent Clinical Trials for ISONIAZID

Identify potential brand extensions & 505(b)(2) entrants

ViiV Healthcare (VH)Phase 2
Fifth Affiliated Hospital, Sun Yat-Sen UniversityN/A
University Medical Center GroningenPhase 1

See all ISONIAZID clinical trials

Pharmacology for ISONIAZID
Medical Subject Heading (MeSH) Categories for ISONIAZID

US Patents and Regulatory Information for ISONIAZID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ISONIAZID isoniazid TABLET;ORAL 085784-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries ISONIAZID isoniazid TABLET;ORAL 083633-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm ISONIAZID isoniazid TABLET;ORAL 080132-004 Jul 14, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Thepharmanetwork Llc ISONIAZID isoniazid TABLET;ORAL 202610-001 Oct 29, 2014 AA RX No No   Start Trial   Start Trial   Start Trial
Sandoz ISONIAZID isoniazid TABLET;ORAL 008678-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.